Let’s see… the 9902b interim trigger will probably occur in 12-18 months (the later, the better for DNDN). Add 3-6 months to process the data and submit it to the FDA (assuming the interim threshold is met). Add another 6 months for the FDA review and you have 21-30 months in all.
So how does DNDN accomplish 21-30 months of work in only 8 months?
If they can do that, they must have a time-compression machine and the stock must be seriously undervalued.
I spoke to someone in ir today ,there is a big chance that we might partner with another co soon to help with all the exp involved ..FDA Approval in the next 8 months...
Take your c**p elsewhere. FDA approval isn't going to happen for at least 10 months after the unblinding of 9902b interim - at the earliest. And by stating something like that you invalidate the rest of your post.
Market Data 
Markets 
AI
